…reast Cancer (MBC) poses a significant clinical challenge where immunotherapies targeting the PD-1/PD-L1 axis have had limited success in contr…
All extracted treatments
Showing 2,281–2,340 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Articles mentioning treatments
7,227 articles · page 502 of 603…minated tumor cells disrupt hematopoietic homeostasis. Although immune checkpoint inhibitor therapy has revolutionized melanoma outcomes, its effects on bone marro…
…oor or no efficacy for the majority of advanced HNSCC patients. Radiation therapy (RT) as an adjuvant treatment is a promising combination partne…
…Background Immunotherapy has transformed treatment paradigms in many malignancies but re…
… tumor cells and host immune system and monitoring responses to immunotherapy. Here we report on the generation of dual reporter syngeneic ce…
…inical trials of immune checkpoint blockade (ICB) combined with chemotherapy delivered only very modest benefits. In this study, we investig…
…1 inhibitors or docetaxel in metastatic NSCLC progressing after platinum therapy. The current study examined the direct effects of TTFields on m…
…ma-bearing mice were treated with R848-loaded nanoparticles and anti-PD1 therapy, in the presence of tamoxifen to fate-map pro-inflammatory TAMs…
…as CD40, a tumor necrosis factor receptor (TNFR) family member. Adoptive cell therapy (ACT) is a promising approach that uses T cells to target and d…
…ll. Accurate subtype identification is critical for determining treatment. However, conventional analyses such as immunohistochemistry (I…
805 Scalable stem cell-derived natural killer cell differentiation in an in vitro feeder-free system
…Background Cell therapies in immuno-oncology have been a critical field in recent years, …
…patients develop therapy resistance, limiting survival benefit. Chimeric antigen receptor natural killer cell (CAR-NK) therapy shows novel promise in cancer treatment with few toxicities in …